Cardinal Health (CAH) Rating Reiterated by Mizuho

Cardinal Health (NYSE:CAH)‘s stock had its “hold” rating restated by stock analysts at Mizuho in a note issued to investors on Sunday. They currently have a $53.00 target price on the stock. Mizuho’s price target would suggest a potential upside of 8.03% from the company’s current price.

Several other brokerages also recently weighed in on CAH. Zacks Investment Research raised Cardinal Health from a “strong sell” rating to a “hold” rating in a report on Tuesday, July 3rd. Robert W. Baird reaffirmed a “hold” rating and set a $51.00 price target on shares of Cardinal Health in a report on Friday, July 20th. Jefferies Financial Group set a $55.00 price target on Cardinal Health and gave the stock a “hold” rating in a report on Friday, May 4th. Leerink Swann set a $65.00 price target on Cardinal Health and gave the stock a “buy” rating in a report on Saturday, May 5th. Finally, Morgan Stanley decreased their price target on Cardinal Health from $55.00 to $40.00 and set an “underweight” rating for the company in a report on Tuesday, July 3rd. Four research analysts have rated the stock with a sell rating, nine have assigned a hold rating and three have given a buy rating to the company. The company presently has an average rating of “Hold” and an average target price of $62.00.

Shares of CAH opened at $49.06 on Friday. The company has a debt-to-equity ratio of 1.32, a quick ratio of 0.54 and a current ratio of 1.07. The company has a market cap of $15.04 billion, a PE ratio of 9.81, a price-to-earnings-growth ratio of 1.78 and a beta of 0.99. Cardinal Health has a 12-month low of $48.14 and a 12-month high of $75.75.

Cardinal Health (NYSE:CAH) last issued its quarterly earnings results on Monday, August 6th. The company reported $1.01 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.93 by $0.08. Cardinal Health had a return on equity of 22.59% and a net margin of 0.19%. The firm had revenue of $35.35 billion during the quarter, compared to the consensus estimate of $34.38 billion. During the same period last year, the company earned $1.31 earnings per share. The company’s revenue for the quarter was up 7.2% on a year-over-year basis. analysts anticipate that Cardinal Health will post 5.04 earnings per share for the current year.

A number of institutional investors have recently added to or reduced their stakes in the business. BB&T Securities LLC lifted its holdings in Cardinal Health by 13.1% in the second quarter. BB&T Securities LLC now owns 92,419 shares of the company’s stock valued at $4,512,000 after acquiring an additional 10,678 shares during the period. AMP Capital Investors Ltd lifted its holdings in Cardinal Health by 26.4% in the second quarter. AMP Capital Investors Ltd now owns 139,568 shares of the company’s stock valued at $6,815,000 after acquiring an additional 29,192 shares during the period. First City Capital Management Inc. lifted its holdings in Cardinal Health by 190.2% in the second quarter. First City Capital Management Inc. now owns 38,357 shares of the company’s stock valued at $1,056,000 after acquiring an additional 25,138 shares during the period. Rampart Investment Management Company LLC lifted its holdings in Cardinal Health by 106.3% in the second quarter. Rampart Investment Management Company LLC now owns 17,406 shares of the company’s stock valued at $850,000 after acquiring an additional 8,970 shares during the period. Finally, OppenheimerFunds Inc. lifted its holdings in Cardinal Health by 29.9% in the second quarter. OppenheimerFunds Inc. now owns 210,457 shares of the company’s stock valued at $10,277,000 after acquiring an additional 48,384 shares during the period. 89.98% of the stock is owned by institutional investors.

Cardinal Health Company Profile

Cardinal Health, Inc operates as an integrated healthcare services and products company worldwide. The company's Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare, and consumer products to retailers, hospitals, and other healthcare providers.

See Also: How Short Selling Works

Analyst Recommendations for Cardinal Health (NYSE:CAH)

Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply